MRKAd5 HIV-1 Gag/Pol/Nef Vaccine-Induced T-Cell Responses Inadequately Predict Distance of Breakthrough HIV-1 Sequences to the Vaccine or Viral Load

被引:30
|
作者
Janes, Holly [1 ,2 ]
Frahm, Nicole [1 ,3 ]
DeCamp, Allan [1 ]
Rolland, Morgane [4 ]
Gabriel, Erin [2 ]
Wolfson, Julian [5 ]
Hertz, Tomer [1 ]
Kallas, Esper [6 ]
Goepfert, Paul [7 ]
Friedrich, David P. [1 ]
Corey, Lawrence [1 ,8 ]
Mullins, James I. [9 ]
McElrath, M. Juliana [1 ,8 ]
Gilbert, Peter [1 ,2 ]
机构
[1] Fred Hutchinson Canc Res Ctr, Div Vaccines & Infect Dis, Seattle, WA 98104 USA
[2] Univ Washington, Dept Biostat, Seattle, WA 98195 USA
[3] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA
[4] US Mil HIV Res Program MHRP, Rockville, MD USA
[5] Univ Minnesota, Div Biostat, Minneapolis, MN USA
[6] Univ Sao Paulo, Div Clin Immunol & Allergy, Sao Paulo, Brazil
[7] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA
[8] Univ Washington, Dept Med, Seattle, WA USA
[9] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA
来源
PLOS ONE | 2012年 / 7卷 / 08期
关键词
FALSE DISCOVERY RATE; MEDIATED-IMMUNITY; STEP; GAG; EPITOPES; ESCAPE; CTL;
D O I
10.1371/journal.pone.0043396
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: The sieve analysis for the Step trial found evidence that breakthrough HIV-1 sequences for MRKAd5/HIV-1 Gag/Pol/Nef vaccine recipients were more divergent from the vaccine insert than placebo sequences in regions with predicted epitopes. We linked the viral sequence data with immune response and acute viral load data to explore mechanisms for and consequences of the observed sieve effect. Methods: Ninety-one male participants (37 placebo and 54 vaccine recipients) were included; viral sequences were obtained at the time of HIV-1 diagnosis. T-cell responses were measured 4 weeks post-second vaccination and at the first or second week post-diagnosis. Acute viral load was obtained at RNA-positive and antibody-negative visits. Findings: Vaccine recipients had a greater magnitude of post-infection CD8+ T cell response than placebo recipients (median 1.68% vs 1.18%; p = 0.04) and greater breadth of post-infection response (median 4.5 vs 2; p = 0.06). Viral sequences for vaccine recipients were marginally more divergent from the insert than placebo sequences in regions of Nef targeted by pre-infection immune responses (p = 0.04; Pol p = 0.13; Gag p = 0.89). Magnitude and breadth of pre-infection responses did not correlate with distance of the viral sequence to the insert (p. 0.50). Acute log viral load trended lower in vaccine versus placebo recipients (estimated mean 4.7 vs 5.1) but the difference was not significant (p = 0.27). Neither was acute viral load associated with distance of the viral sequence to the insert (p>0.30). Interpretation: Despite evidence of anamnestic responses, the sieve effect was not well explained by available measures of T-cell immunogenicity. Sequence divergence from the vaccine was not significantly associated with acute viral load. While point estimates suggested weak vaccine suppression of viral load, the result was not significant and more viral load data would be needed to detect suppression.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] T-cell responses in primary HIV-1 infection
    Streeck, Hendrik
    van Bockel, David
    Kelleher, Anthony
    CURRENT OPINION IN HIV AND AIDS, 2008, 3 (01) : 52 - 59
  • [42] T-cell immune responses induced by canarypox HIV-1 vaccines
    McElrath, MJ
    RETROVIRUSES OF HUMAN AIDS AND RELATED ANIMAL DISEASES, 2003, : 75 - 79
  • [43] Characterization of T-Cell Responses to Cryptic Epitopes in Recipients of a Noncodon-Optimized HIV-1 Vaccine
    Bet, Anne
    Sterrett, Sarah
    Sato, Alicia
    Bansal, Anju
    Goepfert, Paul A.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2014, 65 (02) : 142 - 150
  • [44] Exploitation of Unconventional CD8 T-Cell Responses Induced by Engineered Cytomegaloviruses for the Development of an HIV-1 Vaccine
    Bruton, Joseph
    Hanke, Tomas
    VACCINES, 2025, 13 (01)
  • [45] T lymphocyte responses in HIV-1 infection: implications for vaccine development
    Brander, C
    Walker, B
    CURRENT OPINION IN IMMUNOLOGY, 1999, 11 (04) : 451 - 459
  • [46] Gag and Nef specific T-cell responses in HIV-1 infected long-term non-progressors in Uganda
    Kyosiimire-Lugemwa, J.
    Pala, P.
    Miiro, G.
    Todd, J.
    Kaleebu, P.
    Imami, N.
    Gotch, F.
    RETROVIROLOGY, 2009, 6
  • [47] Towards Novel HIV-1 Serodiagnostic Tests without Vaccine-Induced Seroreactivity
    Lagatie, Ole
    Lauwers, Dax
    Singh, Harvinder
    Vanroye, Fien
    Stieh, Daniel J.
    Vingerhoets, Johan
    Lavreys, Ludo
    Oriol-Mathieu, Valerie
    Colon, Will
    Verhofstede, Chris
    Vercauteren, Koen
    Van den Bossche, Dorien
    Pau, Maria Grazia
    MICROBIOLOGY SPECTRUM, 2023, 11 (03):
  • [48] A study of vaccine-induced immune pressure on breakthrough infections in the Phambili phase 2b HIV-1 vaccine efficacy trial
    Hertz, T.
    Logan, M. G.
    Rolland, M.
    Magaret, C. A.
    Rademeyer, C.
    Fiore-Gartland, A.
    Edlefsen, P. T.
    DeCamp, A.
    Ahmed, H.
    Ngandu, N.
    Larsen, B. B.
    Frahm, N.
    Marais, J.
    Thebus, R.
    Geraghty, D.
    Hural, J.
    Corey, L.
    Kublin, J.
    Gray, G.
    McElrath, M. J.
    Mullins, J. I.
    Gilbert, P. B.
    Williamson, C.
    VACCINE, 2016, 34 (47) : 5792 - 5801
  • [49] Potent immunogenicity of an HIV-1 gag-pol fusion DNA vaccine delivered by in vivo electroporation
    Otten, Gillis R.
    Schaefer, Mary
    Doe, Barbara
    Liu, Hong
    zur Megede, Jan
    Donnelly, John
    Rabussay, Dietmar
    Barnett, Susan
    Ulmer, Jeffrey B.
    VACCINE, 2006, 24 (21) : 4503 - 4509
  • [50] Multi-epitopic B and T cell responses induced in humans by an HIV-1 lipopeptide vaccine
    Guillet, JG
    RETROVIRUSES OF HUMAN AIDS AND RELATED ANIMAL DISEASES, 2000, : 61 - 62